Anthony Digiandomenico - Net Worth and Insider Trading

Anthony Digiandomenico Net Worth

The estimated net worth of Anthony Digiandomenico is at least $5 Million dollars as of 2024-11-05. Anthony Digiandomenico is the Director of Provention Bio Inc and owns about 178,712 shares of Provention Bio Inc (PRVB) stock worth over $4 Million. Anthony Digiandomenico is the Director of Cue Biopharma Inc and owns about 57,000 shares of Cue Biopharma Inc (CUE) stock worth over $97,470. Anthony Digiandomenico is also the Director of ENDRA Life Sciences Inc and owns about 2,049 shares of ENDRA Life Sciences Inc (NDRA) stock worth over $527. Details can be seen in Anthony Digiandomenico's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony Digiandomenico has not made any transactions after 2023-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anthony Digiandomenico

To

Anthony Digiandomenico Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony Digiandomenico owns 7 companies in total, including ENDRA Life Sciences Inc (NDRAU) , Provention Bio Inc (PRVB) , and Cue Biopharma Inc (CUE) among others .

Click here to see the complete history of Anthony Digiandomenico’s form 4 insider trades.

Insider Ownership Summary of Anthony Digiandomenico

Ticker Comapny Transaction Date Type of Owner
NDRAU ENDRA Life Sciences Inc 2020-07-21 director
PRVB Provention Bio Inc 2019-09-30 director
CUE Cue Biopharma Inc 2018-12-28 director
LIMIT LIMIT 2004-08-06 director
LIMIT LIMIT 2004-12-17 director
LIMIT LIMIT 2023-05-02 director
LIMIT LIMIT 2023-07-25 director & 10 percent owner & Chief of Transactions

Anthony Digiandomenico Latest Holdings Summary

Anthony Digiandomenico currently owns a total of 3 stocks. Among these stocks, Anthony Digiandomenico owns 178,712 shares of Provention Bio Inc (PRVB) as of September 30, 2019, with a value of $4 Million and a weighting of 97.85%. Anthony Digiandomenico owns 57,000 shares of Cue Biopharma Inc (CUE) as of December 28, 2018, with a value of $97,470 and a weighting of 2.14%. Anthony Digiandomenico also owns 2,049 shares of ENDRA Life Sciences Inc (NDRA) as of May 2, 2023, with a value of $527 and a weighting of 0.01%.

Latest Holdings of Anthony Digiandomenico

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRVB Provention Bio Inc 2019-09-30 178,712 24.98 4,464,226
CUE Cue Biopharma Inc 2018-12-28 57,000 1.71 97,470
NDRA ENDRA Life Sciences Inc 2023-05-02 2,049 0.26 527

Holding Weightings of Anthony Digiandomenico


Anthony Digiandomenico Form 4 Trading Tracker

According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 0 transactions in Provention Bio Inc (PRVB) over the past 5 years. The most-recent trade in Provention Bio Inc is the acquisition of 30,000 shares on September 30, 2019, which cost Anthony Digiandomenico around $204,900.

According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 0 transactions in Cue Biopharma Inc (CUE) over the past 5 years. The most-recent trade in Cue Biopharma Inc is the acquisition of 7,000 shares on December 28, 2018, which cost Anthony Digiandomenico around $32,340.

According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 4 transactions in ENDRA Life Sciences Inc (NDRA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in ENDRA Life Sciences Inc is the acquisition of 1,667 shares on May 2, 2023, which cost Anthony Digiandomenico around $100,000.

Insider Trading History of Anthony Digiandomenico

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anthony Digiandomenico Trading Performance

GuruFocus tracks the stock performance after each of Anthony Digiandomenico's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Digiandomenico is 24.91%. GuruFocus also compares Anthony Digiandomenico's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Digiandomenico within 3 months outperforms 15 times out of 25 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anthony Digiandomenico's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anthony Digiandomenico

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
24 out of 25 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.01 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.32 LIMIT LIMIT LIMIT LIMIT LIMIT

Anthony Digiandomenico Ownership Network

Ownership Network List of Anthony Digiandomenico

No Data

Ownership Network Relation of Anthony Digiandomenico

Insider Network Chart

Anthony Digiandomenico Owned Company Details

What does ENDRA Life Sciences Inc do?

Who are the key executives at ENDRA Life Sciences Inc?

Anthony Digiandomenico is the director of ENDRA Life Sciences Inc. Other key executives at ENDRA Life Sciences Inc include Chief Commercial Officer Renaud Bertrand Maloberti , Chief Technology Officer Michael Milos Thornton , and Chief Financial Officer David R. Wells .

ENDRA Life Sciences Inc (NDRAU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ENDRA Life Sciences Inc (NDRAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ENDRA Life Sciences Inc (NDRAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ENDRA Life Sciences Inc (NDRAU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ENDRA Life Sciences Inc Insider Transactions

No Available Data

Anthony Digiandomenico Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony Digiandomenico. You might contact Anthony Digiandomenico via mailing address: 3600 Green Court, Suite 350, Ann Arbor Mi 48105.